Search
for
Sort by
Research 181–210 of 1000+
- Genetics Poly Cystic Ovary Syndrome
- Dermatitis as a Presenting Sign of Cystic Fibrosis
- Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient
- A CASE REPORT - AYURVEDA MANAGEMENT OF POLY CYSTIC OVARIAN DISEASE (PCOD)
- Severe adverse reaction induced by albendazole and praziquantel for cystic echinococcosis
- Anti-Mullerian Hormone as A new Marker for Diagnosis of Poly Cystic Ovary Syndrome
- Nutraceutical Intervention of Seeds in the Treatment of Poly Cystic Ovarian Syndrome; A Systematic Review
- 1171 Obstructive Sleep Apnea and Its Effect on Non-Cystic Fibrosis Bronchiectasis Exacerbations: A National Inpatient Sample Study
- A Review and a Brief Explanation of the Poly Cystic Ovarian Syndrome
- Nutritional Assessment of Selected Emerging Adult Women with Poly Cystic Ovarian Syndrome
- Review on methods and mechanisms available for producing poly cystic ovary syndrome (PCOS) in animal models: experimental purpose (pre-clinical studies)
- ASSESSMENT OF HEALTH RELATED QUALITY OF LIFE IN POLY CYSTIC OVARIAN SYNDROME PATIENTS AND FACTORS AFFECTING OVARIAN FOLLICULAR SIZE
- Isolated Human Skin Glands and Appendages: Models for Cystic Fibrosis, Acne Vulgaris, Alopecia and Hidradenitis Suppurativa
- Das Phototrichogramm als Verfahren zur Beurteilung haarwachstumsfördernder Präparate am Beispiel einer Kombination von Hirsefruchtextrakt, L-Cystin und Calciumpantothenat : Ergebnisse einer in vivo Untersuchung bei Frauen mit androgenetischem Haarausfall
- Surprisingly low infertility rate in married type 2 diabetic women: A rather curious paradox to the current opinion of insulin resistance as the joint pathogenesis of poly cystic ovary syndrome and type 2 diabetes mellitus
- Randomisierte, doppelblind Placebo-kontrollierte Studie zur Wirksamkeit eines spezifischen, CYP (Cystin, Medizinalhefe, Pantothensäure)-Komplex-haltigen Arzneimittels zur Nahrungsergänzung (Pantogar) bei Frauen 60+ mit Haarausfall
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Anthelmintic effect of Mentha spp. essential oils on Echinococcus granulosus protoscoleces and metacestodes
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Apparent Cortisone Reductase Deficiency: A Rare Cause of Hyperandrogenemia and Hypercortisolism
- Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Disruption of tubular Flcn expression as a mouse model for renal tumor induction
- The Use of Photodynamic Therapy for Treatment of Acne Vulgaris
- Problems in evaluating chronic toxicity of contraceptive steroids in dogs
- Studies of the components of an oral contraceptive agent in albino rats. II. Progestogenic component and comparison of effects of the components and the combined agent
- Ornithine decarboxylase transgenic mice as a model for human atrichia with papular lesions
- Alopecia Mucinosa
- Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
- Two Clinically Unusual Cases of Folliculotropic Mycosis Fungoides: One with and the Other without Syringotropism